Skip to main content

Published locations for Hospitalized COVID-19 patients with cardiometabolic risk do not benefit from dapagliflozin

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Hospitalized COVID-19 patients with cardiometabolic risk do not benefit from dapagliflozin

User login

  • Reset your password
  • /content/hospitalized-covid-19-patients-cardiometabolic-risk-do-not-benefit-dapagliflozin
  • /icymi-covid/article/246900/covid-19/hospitalized-covid-19-patients-cardiometabolic-risk-do-not